Fri, Oct 28, 2016
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.32% in April (3.24% YTD), Healthcare & Biotechnology index best performer with +3.45% (6.10% YTD)

Monday, May 16, 2011
Opalesque Industry Update – Hedge funds gained 1.32% in April according to the Barclay Hedge Fund Index compiled by BarclayHedge. Year-to-date the Index is up 3.24%.

“Higher prices for equities and bonds in April provided an accommodating environment for most hedge fund strategies,” says Sol Waksman, founder and president of BarclayHedge.

“Strength in the bond market despite US dollar weakness and a well bid equity market took many participants by surprise,” says Waksman. “Yet looking at the positive returns of fixed income-based strategies in April, it appears that hedge fund managers were not caught unawares.

All but two of Barclay’s 18 hedge fund indices had gains in April. The Barclay Healthcare & Biotechnology Index was up 3.45%, Technology gained 2.67%, Global Macro was up 1.96%, Emerging Markets gained 1.82%, and the European Equities Index rose 1.78%.

“Hedge funds have made steady progress since September of 2010, as evidenced by eight straight months of gains for the Barclay Hedge Fund Index,” says Waksman.

The Equity Short Bias Index has lost ground for eight months in a row and gave up another 1.94% in April. Equity Short Bias is down 7.66% year-to-date.

The Barclay Fund of Funds Index gained 1.14% in April and is up 1.98% in 2011.

(press release)

Performance tables: Source

BarclayHedge was founded in 1985 and actively tracks more than 6,000 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories and 16 CTA categories.


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. David Einhorn speaks on passive investing, Mylan, his cheapest stock, the Fed[more]

    From Greenlight Capital hedge fund manager David Einhorn (Trades, Portfolio) joined nine other famed investors on Tuesday to talk about stocks at the annual Great Investors’ Best Ideas Investment Symposium in Dallas. Presenters at the annual conference typically pitch one or severa

  2. Investing - Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities, Lansdowne's Roden says likes animal genetics company Genus[more]

    Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities From As ValueWalk reported back in February, earlier this year Andrew Lawrence set out to raise $250 million to $500 million for a fund that will buy stakes in hedge funds that have suspended redem

  3. Opalesque Roundtable: Style drift, poor communications and credibility fatigue are biggest red flags for hedge funds investors[more]

    Komfie Manalo, Opalesque Asia: Style drift, poor communications and credibility fatigue are the biggest red flags for hedge funds investors, said participants of the latest 2016 Opalesque Investor Roundtable, sponso

  4. Barclay CTA Index down 0.40% in September (+0.10% YTD)[more]

    Managed futures traders lost 0.40% in September according to the Barclay CTA Index compiled by BarclayHedge. The Index is up 0.10% year to date. “The US Fed, in spite of its hawkish tone, opted to hold rates steady which roiled financial markets,” says Sol Waksman, founder and president of BarclayHe

  5. Opalesque Exclusive: Meet Emma, your friendly A.I. helper[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Shaunka Khire, who co-designed an artificial intelligence (AI) robot called EMMA/MANSI, talks to Opalesque